Tianjin Ringpu Bio-Technology Co.,Ltd. (SHE:300119)

SHE:300119 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	3,526	3,045	2,684	2,063	1,987	1,984
Other Revenue	24.01	25.33	24.98	21.44	20.23	16.09
Revenue	3,550	3,070	2,709	2,084	2,007	2,000
Revenue Growth (YoY)	11.40%	13.32%	29.98%	3.84%	0.34%	36.40%
Cost of Revenue	2,143	1,820	1,527	1,075	969.26	920.78
Gross Profit	1,407	1,250	1,182	1,010	1,038	1,080
Selling, General & Admin	717.62	640.33	584.43	486.89	529.17	521.48
Research & Development	217.9	196.04	172.47	132.1	116.64	110.96
Other Operating Expenses	22.05	21.89	20.04	20.4	18.97	18.44
Operating Expenses	952.69	874.82	803.78	659.1	682.72	680.24
Operating Income	454.47	375.04	378.65	350.43	355.16	399.38
Interest Expense	-8.97	-31.21	-25.42	-28.43	-23.82	-27.17
Interest & Investment Income	68.63	14.11	20.81	15.25	24.27	4.88
Currency Exchange Gain (Loss)	0.78	0.78	0.51	0.41	-0.28	-1.21
Other Non Operating Income (Expenses)	-53.95	-4.63	-6.12	0.43	-3.21	-1.25
EBT Excluding Unusual Items	460.97	354.08	368.42	338.1	352.12	374.63
Gain (Loss) on Sale of Investments	10.29	-10.71	61.26	51.38	113.8	116.75
Gain (Loss) on Sale of Assets	3.83	-0.02	114.09	-0.01	0.1	-0.02
Asset Writedown	-0.15	-0.14	-0.47	-0.11	-9.1	-1.34
Other Unusual Items	21.63	25.07	27.89	22.16	30.88	20.9
Pretax Income	496.57	368.29	571.19	413.81	487.79	510.92
Income Tax Expense	49.68	38.46	56.18	40.04	54.2	71.43
Earnings From Continuing Operations	446.89	329.83	515	373.77	433.59	439.49
Minority Interest in Earnings	-32.24	-29.11	-61.41	-27.07	-20.81	-41.29
Net Income	414.65	300.72	453.59	346.7	412.78	398.2
Net Income to Common	414.65	300.72	453.59	346.7	412.78	398.2
Net Income Growth	-3.18%	-33.70%	30.83%	-16.01%	3.66%	104.88%
Shares Outstanding (Basic)	456	460	464	463	402	396
Shares Outstanding (Diluted)	456	460	464	463	402	396
Shares Change (YoY)	-1.17%	-0.69%	0.11%	15.06%	1.61%	-0.28%
EPS (Basic)	0.91	0.65	0.98	0.75	1.03	1.01
EPS (Diluted)	0.91	0.65	0.98	0.75	1.03	1.01
EPS Growth	-2.04%	-33.24%	30.69%	-27.00%	2.02%	105.46%
Free Cash Flow	414.03	550.21	158.47	17.05	76.75	129.27
Free Cash Flow Per Share	0.91	1.20	0.34	0.04	0.19	0.33
Dividend Per Share	0.300	0.300	0.400	0.300	0.350	0.400
Dividend Growth	-25.00%	-25.00%	33.33%	-14.29%	-12.50%	60.00%
Gross Margin	39.64%	40.71%	43.65%	48.44%	51.71%	53.97%
Operating Margin	12.80%	12.22%	13.98%	16.81%	17.70%	19.96%
Profit Margin	11.68%	9.80%	16.74%	16.63%	20.57%	19.91%
Free Cash Flow Margin	11.66%	17.92%	5.85%	0.82%	3.82%	6.46%
EBITDA	687.09	567.43	517.4	457.89	439.13	495.13
EBITDA Margin	19.36%	18.48%	19.10%	21.97%	21.88%	24.75%
D&A For EBITDA	232.62	192.39	138.76	107.45	83.97	95.75
EBIT	454.47	375.04	378.65	350.43	355.16	399.38
EBIT Margin	12.80%	12.22%	13.98%	16.81%	17.70%	19.96%
Effective Tax Rate	10.00%	10.44%	9.84%	9.68%	11.11%	13.98%
Revenue as Reported	1,005	3,070	2,709	2,084	2,007	2,000
Advertising Expenses	-	13.04	7.44	6.64	7.72	6.51

Source: S&P Global Market Intelligence. Standard template. Financial Sources.